45 related articles for article (PubMed ID: 33162447)
41. [HHV-8-positive Castleman's disease with rapidly progressing multiorgan failure mimicking TAFRO syndrome].
Ide S; Ohara S; Uchida T; Inoue M; Hagihara M
Rinsho Ketsueki; 2020; 61(10):1497-1501. PubMed ID: 33162447
[TBL] [Abstract][Full Text] [Related]
42. Fatal case of TAFRO syndrome associated with over-immunosuppression: a case report and review of the literature.
Matsuhisa T; Takahashi N; Nakaguro M; Sato M; Inoue E; Teshigawara S; Ozawa Y; Kondo T; Nakamura S; Sato J; Ban N
Nagoya J Med Sci; 2019 Aug; 81(3):519-528. PubMed ID: 31579342
[TBL] [Abstract][Full Text] [Related]
43. Castleman disease and TAFRO syndrome.
Masaki Y; Arita K; Sakai T; Takai K; Aoki S; Kawabata H
Ann Hematol; 2022 Mar; 101(3):485-490. PubMed ID: 35044513
[TBL] [Abstract][Full Text] [Related]
44. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
[TBL] [Abstract][Full Text] [Related]
45. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
